Rui Feng

faculty photo
Associate Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Department: Biostatistics and Epidemiology

Contact information
423 Guardian Drive
209 Blockley Hall
Department of Biostatistics, Epidemiology and Informatics
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA 19104
Office: 215-746-4473
Fax: 215-573-4865
Education:
B.S. (Mathematics)
University of Science and Technology of China, 1999.
M.S. (Statistics)
The Johns Hopkins University, 2001.
Ph.D. (Biostatistics)
Yale University, 2005.
Permanent link
 

Description of Itmat Expertise

Biostatistics
Genetics
Epigenetics

Description of Research Expertise

Biostatistics;
Big data;
Statistical genetics;
Genomics;
Clinical trials;
Data coordinating center.

Selected Publications

Mittal L, Zhang L, Feng R, Werth VP.: Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study. J Am Acad Dermatol. 78(1): 100-106, Jan 2018.

Meyer NJ, Reilly JP, Anderson BJ, Palakshappa JA, Jones TK, Dunn TG, Shashaty MGS, Feng R, Christie JD, Opal SM.: Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration. Critical Care Medicine. 46((1)): 21-28, Jan 2018.

Meyer NJ, Reilly JP, Feng R, Christie JD, Hazen SL, Albert CJ, Franke JD, Hartman CL, McHowat J, Ford DA.: Myeloperoxidase-derived 2-chlorofatty acids contribute to human sepsis mortality via acute respiratory distress syndrome. JCI Insight 2(23): 96432, Dec 2017.

Yu X., Chen G., Feng R.: An Efficient Study Design to Test Parent-of-Origin Effects in Family Trios. Genetic Epidemiology 41(7): 587-598, Nov 2017 Notes: doi: 10.1002/gepi.22060. [Epub ahead of print]

Robinson ES, Alves P, Bashir MM, Zeidi M, Feng R, Werth VP: Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro Journal of Investigative Dermatology 137(11): 2445-2447, Nov 2017.

Chansky PB, Olazagasti JM, Feng R, Werth VP.: Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI). J Am Acad Dermatol. S0190-9622(17): 32578-1, Oct 2017.

Alves P, Bashir M, Wysocka M, Zeidi M, Feng R, Werth VP: Quinacrine Suppresses Tumor Necrosis Factor-α and Interferon-α in Dermatomyositis and Cutaneous Lupus Erythematosus. Journal of Investigative Dermatology Symposium Proceedings 18(2): S57-S63, Oct 2017.

Kim HJ, Langenhan JL, Robinson ES, Privette E, Achtman JC, Mitrani RA, Zeidi M, Sharma MR, Feng R, Nevas JL, Calianno C, Okawa J, Taylor L, Pappas-Taffer L, Werth VP.: Effect of long-term treatment with tumour necrosis factor-α inhibitors on single-dose ultraviolet-induced changes in human skin. Br J Dermatol. Aug 2017 Notes: In press.

Keller R, Feng R, Shaw P, Bellamy S, Ferkol T, Rogers E, Stevens T, Voynow J, Hardie B, DeMauro S, and Moore P: Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. Journal of Pediatrics 187: 89-97, Aug 2017.

Anyanwu CO, Chansky PB, Feng R, Carr K, Okawa J, Werth VP.: The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy. Int J Womens Dermatol. 13(3(4)): 189-194, Jun 2017.

back to top
Last updated: 04/09/2018
The Trustees of the University of Pennsylvania